Mikiko Watanabe
About
In The Last Decade
Mikiko Watanabe
72 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Physiology 895
- Endocrinology, Diabetes and Metabolism 577
- Molecular Biology 447
- Infectious Diseases 383
- Epidemiology 382
Countries citing papers authored by Mikiko Watanabe
This map shows the geographic impact of Mikiko Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikiko Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikiko Watanabe more than expected).
Fields of papers citing papers by Mikiko Watanabe
This network shows the impact of papers produced by Mikiko Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikiko Watanabe. The network helps show where Mikiko Watanabe may publish in the future.
Co-authorship network of co-authors of Mikiko Watanabe
This figure shows the co-authorship network connecting the top 25 collaborators of Mikiko Watanabe. A scholar is included among the top collaborators of Mikiko Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikiko Watanabe. Mikiko Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 52 | |
| 8 | 26 | |
| 9 | 32 | |
| 10 | 7 | |
| 11 | 29 | |
| 12 | 13 | |
| 13 | Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccine breakdown → | 190 |
| 14 | 2 | |
| 15 | 23 | |
| 16 | 10 | |
| 17 | 28 | |
| 18 | 23 | |
| 19 | 25 | |
| 20 | 31 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.